NS1209

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	AP245063596
CAS	245063-59-6
MDL Number	MFCD09955227
Molecular Weight	516.57

Description	≥98% (HPLC)
Solubility	DMSO: 2 mg/mL, clear
Assay	≥98% (HPLC)
Color	white to beige
Form	powder
Size	5MG, 25MG
Storage Conditions	2-8°C

1Do Traditional Anti-Seizure Drugs Have a Future? A Review of Potential Anti-Seizure Drugs in Clinical Development

Gaetano Zaccara, Dieter Schmidt

Pharmacol Res. 2016 Feb;104:38-48.

PMID: 26689774

1Effect of Novel AMPA Antagonist, NS1209, on Status Epilepticus. An Experimental Study in Rat

Asla Pitkänen, Claus Mathiesen, Lars Christian B Rønn, Arne Møller, Jari Nissinen

Epilepsy Res. 2007 Apr;74(1):45-54.

PMID: 17289347

1NS1209/SPD 502, A Novel Selective AMPA Antagonist for Stroke, Neuropathic Pain or Epilepsy? Drug Development Lessons Learned

Jan M Keppel Hesselink

Drug Dev Res. 2017 Mar;78(2):75-80.

PMID: 28195646

1The Efficacy of the AMPA Receptor Antagonist NS1209 and Lidocaine in Nerve Injury Pain: A Randomized, Double-Blind, Placebo-Controlled, Three-Way Crossover Study

Lise Gormsen, Nanna B Finnerup, Per M Almqvist, Troels S Jensen

Anesth Analg. 2009 Apr;108(4):1311-9.

PMID: 19299805

1The Structure of a Mixed GluR2 Ligand-Binding Core Dimer in Complex With (S)-glutamate and the Antagonist (S)-NS1209

Christina Kasper, Darryl S Pickering, Osman Mirza, Lars Olsen, Anders S Kristensen, Jeremy R Greenwood, Tommy Liljefors, Arne Schousboe, Frank Wätjen, Michael Gajhede, Bent W Sigurskjold, Jette S Kastrup

J Mol Biol. 2006 Apr 7;357(4):1184-201.

PMID: 16483599

* Products or Services Interested: NS1209 (245063-59-6)
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

NS1209

Send Us a Request

Inquiry

Head Office

Follow us on